Fusion Biopsy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

The global fusion biopsy market has witnessed remarkable growth during forecast period. According to a recent industry analysis report by Fairfield Market Research, the market is projected to achieve a staggering valuation of US$ 2.1 billion by 2031. This surge is attributed to several factors driving the demand for fusion biopsy.

Driving Factors for Fusion Biopsy Demand

Prostate cancer diagnoses have been on the rise, necessitating advanced diagnostic techniques. Fusion biopsy has emerged as a critical tool in this context. It aids in reducing the number of biopsy tests needed and is highly effective in detecting concealed tumors, particularly aggressive ones that may be missed by other biopsy methods. By combining MRI and ultrasound images, fusion biopsy enables targeted biopsies, making it especially useful for individuals with negative previous biopsies or those who have never undergone a biopsy.

U.S. Leads the Fusion Biopsy Market

The United States is a key player in the fusion biopsy market, with a promising outlook for future growth. Factors propelling this growth include the increasing adoption of image-guided biopsy techniques, particularly those utilizing multi-parametric Magnetic Resonance Imaging (MRI), in precision medicine applications. Furthermore, innovative biopsy technologies, increased clinical utilization, and improvements in treatment quality are expected to drive market expansion. The aging population and a rising number of cancer cases contribute to this growth.

UK, Japan, and South Korea Show Growth Potential

The fusion biopsy market in the United Kingdom, Japan, and South Korea is poised for significant growth as well. These regions are expected to witness notable Compound Annual Growth Rates (CAGRs) during the forecast period, resulting in substantial market sizes and absolute dollar opportunities.

Australia's commitment to prostate cancer research and treatment through organizations like Cancer Australia, Prostate Cancer Research Foundation Australia, and the National Health and Medical Research Council is a positive step in the right direction. Such investments can lead to advancements in understanding the disease, early detection methods, and innovative treatments.

Prostate cancer is a significant health concern for men worldwide, and research funding plays a pivotal role in driving progress in this field. It not only helps in improving diagnostic accuracy but also in developing more targeted and effective therapies, ultimately leading to better outcomes and improved quality of life for those affected by the disease.

Competitive Landscape Analysis

In recent years, technological advancements and expansion strategies have been prominent in the fusion biopsy market.

Key Companies Profiled:

1. Koninklijke Philips N.V.
2. Hitachi Ltd.
3. MedCom
4. ESAOTE SPA
5. KOELIS
6. Focal Healthcare
7. GeoScan Medical
8. UC-Care Medical Systems Ltd.

The fusion biopsy market's rapid growth underscores the importance of innovative diagnostic solutions in the field of cancer diagnosis and treatment. As the prevalence of prostate cancer continues to rise, the fusion biopsy market is poised to play a crucial role in early detection and improved patient outcomes.

Market Segments Covered in Fusion biopsy Industry Analysis

By Biopsy Route

Transperineal
Transrectal

By End Use

Hospitals
Diagnostic Centers
Ambulatory Care Centers

By Region

North America
- U.S.
- Canada

Europe
- U.K.
- Germany
- France
- Italy
- Spain

Asia Pacific
- Japan
- China
- India
- Thailand
- South Korea

Latin America
- Brazil
- Mexico
- Argentina
- Colombia

Middle East & Africa
- South Africa
- Saudi Arabia

1. Executive Summary

1.1. Global Fusion Biopsy Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Fusion Biopsy Market Outlook, 2018 - 2031

3.1. Global Fusion Biopsy Market Outlook, by Biopsy Route, Value (US$ Bn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Transperineal
  - 3.1.1.2. Transrectal
3.2. Global Fusion Biopsy Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Hospitals
  - 3.2.1.2. Diagnostic Centers
  - 3.2.1.3. Ambulatory Care Centers
3.3. Global Fusion Biopsy Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. North America
  - 3.3.1.2. Europe
  - 3.3.1.3. Asia Pacific
  - 3.3.1.4. Latin America
  - 3.3.1.5. Middle East & Africa

4. North America Fusion Biopsy Market Outlook, 2018 - 2031

4.1. North America Fusion Biopsy Market Outlook, by Biopsy Route, Value (US$ Bn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Transperineal
  - 4.1.1.2. Transrectal
4.2. North America Fusion Biopsy Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Hospitals
  - 4.2.1.2. Diagnostic Centers
  - 4.2.1.3. Ambulatory Care Centers
- 4.2.2. BPS Analysis/Market Attractiveness Analysis
4.3. North America Fusion Biopsy Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. U.S. Fusion Biopsy Market by Biopsy Route, Value (US$ Bn), 2018 - 2031
  - 4.3.1.2. U.S. Fusion Biopsy Market by End User, Value (US$ Bn), 2018 - 2031
  - 4.3.1.3. Canada Fusion Biopsy Market by Biopsy Route, Value (US$ Bn), 2018 - 2031
  - 4.3.1.4. Canada Fusion Biopsy Market by End User, Value (US$ Bn), 2018 - 2031
- 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Fusion Biopsy Market Outlook, 2018 - 2031

5.1. Europe Fusion Biopsy Market Outlook, by Biopsy Route, Value (US$ Bn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Transperineal
  - 5.1.1.2. Transrectal
5.2. Europe Fusion Biopsy Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Hospitals
  - 5.2.1.2. Diagnostic Centers
  - 5.2.1.3. Ambulatory Care Centers
- 5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe Fusion Biopsy Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Germany Fusion Biopsy Market by Biopsy Route, Value (US$ Bn), 2018 - 2031
  - 5.3.1.2. Germany Fusion Biopsy Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.3. U.K. Fusion Biopsy Market by Biopsy Route, Value (US$ Bn), 2018 - 2031
  - 5.3.1.4. U.K. Fusion Biopsy Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.5. France Fusion Biopsy Market by Biopsy Route, Value (US$ Bn), 2018 - 2031
  - 5.3.1.6. France Fusion Biopsy Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.7. Italy Fusion Biopsy Market by Biopsy Route, Value (US$ Bn), 2018 - 2031
  - 5.3.1.8. Italy Fusion Biopsy Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.9. Turkey Fusion Biopsy Market by Biopsy Route, Value (US$ Bn), 2018 - 2031
  - 5.3.1.10. Turkey Fusion Biopsy Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.11. Russia Fusion Biopsy Market by Biopsy Route, Value (US$ Bn), 2018 - 2031
  - 5.3.1.12. Russia Fusion Biopsy Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.13. Rest of Europe Fusion Biopsy Market by Biopsy Route, Value (US$ Bn), 2018 - 2031
  - 5.3.1.14. Rest of Europe Fusion Biopsy Market by End User, Value (US$ Bn), 2018 - 2031
- 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Fusion Biopsy Market Outlook, 2018 - 2031

6.1. Asia Pacific Fusion Biopsy Market Outlook, by Biopsy Route, Value (US$ Bn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Transperineal
  - 6.1.1.2. Transrectal
6.2. Asia Pacific Fusion Biopsy Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Hospitals
  - 6.2.1.2. Diagnostic Centers
  - 6.2.1.3. Ambulatory Care Centers
- 6.2.2. Others BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Fusion Biopsy Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. China Fusion Biopsy Market by Biopsy Route, Value (US$ Bn), 2018 - 2031
  - 6.3.1.2. China Fusion Biopsy Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.3. Japan Fusion Biopsy Market by Biopsy Route, Value (US$ Bn), 2018 - 2031
  - 6.3.1.4. Japan Fusion Biopsy Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.5. South Korea Fusion Biopsy Market by Biopsy Route, Value (US$ Bn), 2018 - 2031
  - 6.3.1.6. South Korea Fusion Biopsy Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.7. India Fusion Biopsy Market by Biopsy Route, Value (US$ Bn), 2018 - 2031
  - 6.3.1.8. India Fusion Biopsy Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.9. Southeast Asia Fusion Biopsy Market by Biopsy Route, Value (US$ Bn), 2018 - 2031
  - 6.3.1.10. Southeast Asia Fusion Biopsy Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.11. Rest of Asia Pacific Fusion Biopsy Market by Biopsy Route, Value (US$ Bn), 2018 - 2031
  - 6.3.1.12. Rest of Asia Pacific Fusion Biopsy Market by End User, Value (US$ Bn), 2018 - 2031
- 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Fusion Biopsy Market Outlook, 2018 - 2031

7.1. Latin America Fusion Biopsy Market Outlook, by Biopsy Route, Value (US$ Bn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Transperineal
  - 7.1.1.2. Transrectal
7.2. Latin America Fusion Biopsy Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Fusion Biopsy Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Brazil Fusion Biopsy Market by Biopsy Route, Value (US$ Bn), 2018 - 2031
  - 7.3.1.2. Brazil Fusion Biopsy Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.3.1.3. Mexico Fusion Biopsy Market by Biopsy Route, Value (US$ Bn), 2018 - 2031
  - 7.3.1.4. Mexico Fusion Biopsy Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.3.1.5. Argentina Fusion Biopsy Market by Biopsy Route, Value (US$ Bn), 2018 - 2031
  - 7.3.1.6. Argentina Fusion Biopsy Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.3.1.7. Rest of Latin America Fusion Biopsy Market by Biopsy Route, Value (US$ Bn), 2018 - 2031
  - 7.3.1.8. Rest of Latin America Fusion Biopsy Market by End User, Value (US$ Bn), 2018 - 2031
- 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Fusion Biopsy Market Outlook, 2018 - 2031

8.1. Middle East & Africa Fusion Biopsy Market Outlook, by Biopsy Route, Value (US$ Bn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Transperineal
  - 8.1.1.2. Transrectal
8.2. Middle East & Africa Fusion Biopsy Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Hospitals
  - 8.2.1.2. Diagnostic Centers
  - 8.2.1.3. Ambulatory Care Centers
- 8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa Fusion Biopsy Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. GCC Fusion Biopsy Market by Biopsy Route, Value (US$ Bn), 2018 - 2031
  - 8.3.1.2. GCC Fusion Biopsy Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.3.1.3. South Africa Fusion Biopsy Market by Biopsy Route, Value (US$ Bn), 2018 - 2031
  - 8.3.1.4. South Africa Fusion Biopsy Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.3.1.5. Egypt Fusion Biopsy Market by Biopsy Route, Value (US$ Bn), 2018 - 2031
  - 8.3.1.6. Egypt Fusion Biopsy Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.3.1.7. Nigeria Fusion Biopsy Market by Biopsy Route, Value (US$ Bn), 2018 - 2031
  - 8.3.1.8. Nigeria Fusion Biopsy Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.3.1.9. Rest of Middle East & Africa Fusion Biopsy Market by Biopsy Route, Value (US$ Bn), 2018 - 2031
  - 8.3.1.10. Rest of Middle East & Africa Fusion Biopsy Market by End User, Value (US$ Bn), 2018 - 2031
- 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Manufacturer vs by End User Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
- 9.4.1. Eigen
  - 9.4.1.1. Company Overview
  - 9.4.1.2. Product Portfolio
  - 9.4.1.3. Financial Overview
  - 9.4.1.4. Business Strategies and Development
- 9.4.2. Koninklijke Philips N.V.
  - 9.4.2.1. Company Overview
  - 9.4.2.2. Product Portfolio
  - 9.4.2.3. Financial Overview
  - 9.4.2.4. Business Strategies and Development
- 9.4.3. Hitachi Ltd.
  - 9.4.3.1. Company Overview
  - 9.4.3.2. Product Portfolio
  - 9.4.3.3. Financial Overview
  - 9.4.3.4. Business Strategies and Development
- 9.4.4. MedCom
  - 9.4.4.1. Company Overview
  - 9.4.4.2. Product Portfolio
  - 9.4.4.3. Financial Overview
  - 9.4.4.4. Business Strategies and Development
- 9.4.5. ESAOTE SPA
  - 9.4.5.1. Company Overview
  - 9.4.5.2. Product Portfolio
  - 9.4.5.3. Financial Overview
  - 9.4.5.4. Business Strategies and Development
- 9.4.6. KOELIS
  - 9.4.6.1. Company Overview
  - 9.4.6.2. Product Portfolio
  - 9.4.6.3. Financial Overview
  - 9.4.6.4. Business Strategies and Development
- 9.4.7. Focal Healthcare
  - 9.4.7.1. Company Overview
  - 9.4.7.2. Product Portfolio
  - 9.4.7.3. Financial Overview
  - 9.4.7.4. Business Strategies and Development
- 9.4.8. GeoScan Medical
  - 9.4.8.1. Company Overview
  - 9.4.8.2. Product Portfolio
  - 9.4.8.3. Financial Overview
  - 9.4.8.4. Business Strategies and Development
- 9.4.9. UC-Care Medical Systems Ltd.
  - 9.4.9.1. Company Overview
  - 9.4.9.2. Product Portfolio
  - 9.4.9.3. Financial Overview
  - 9.4.9.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations